GLP-1RAs are generally recommended for patients with T2D whose glycated haemoglobin (HbA 1c ) is above target despite diet, exercise and existing glucose-lowering medication, and GLP-1RAs with proven cardiovascular benefit are also recommended in patients with T2D at elevated cardiovascular risk, regardless of HbA 1c [5, 6]
Published on December 31st, 2025
Even with these limitations, wanting-related measures show a relatively recurring pattern of reduced craving or reduced responsiveness to highly palatable food cues across several studies
The law does not apply to foods (i.e., products labeled with a Nutrition Facts panel)
CJC-1295: Side-by-Side Comparison A Direct Comparison
McQuaid SE, Hodson L, Neville MJ, Dennis AL, Cheeseman J, Humphreys SM, et al